Sort by: Date added | Date Published | Most Viewed

Headlines Tagged with Harm Reduction 4,558 headlines found

2 Views

[New York] Vaping: Parents, school districts, FDA face e-cigarette learning curve

Students from local school districts asked Northern Westchester Hospital in 2018 to focus on vaping during regional health-education programs. The request came after a student leadership council recognized the urgency of combating rampant vaping at their
New York Journal News
added Aug 30, 2018 17:00
5 Views

BENTLEY: E-cigarette tariffs are a threat to public health

There are around 10,000 vape shops in the U.S. These stores are achieving something that FDA and anti-smoking groups never have–make quitting smoking enjoyable. As FDA itself has acknowledged, nicotine is not the problem but the harmful smoke from cigare
The Hill
added Aug 29, 2018 23:40
8 Views

Reduced-Risk Warnings versus the U.S. FDA-Mandated Addiction Warning: The Effects of E-Cigarette Warning Variations on Health Risk Perceptions

findings show that overall health risk perceptions and addiction risk perceptions based on the addiction warning are greater than risk perceptions based on the reduced-risk warnings. In contrast, specific disease-related risk perceptions, such as cancer a
Nicotine and Tobacco Research
added Aug 28, 2018 18:36
10 Views

UK Malboro boss wishes he could stop selling cigarettes tomorrow...as Philip Morris launches bold campaign to get people switching to its iQos devices

Tastefully put together with hues of white, grey and copper, the beautifully designed shop mysteriously shows little evidence of any product for sale. Instead, there is an interactive display along the far wall to educate aspiring non-smokers on heated
The Daily Mail and Mail on Sunday (uk)
added Aug 26, 2018 16:41
4 Views

GLANTZ: RJR's consumer perceptions studies are poorly designed and fail to provide sufficient evidence for FDA to allow RJR to market Camel Snus as less dangerous; likely to make readers thing they are safe

Lucy Popova from GSU, Lauren Lempert, Pam Ling, and I submitted this comment to FDA on RJR's application to see Camel Snus as a reduced risk product. The regulations.gov tracking number is 1k2-9510-dtqo. A PDF of the comment is available here.
Center for Tobacco Control Research and Education (UCSF)
added Aug 26, 2018 14:52
7 Views

FELSHER: R.J. Reynolds Tobacco Company’s Application for Six Camel SNUS Smokeless Tobacco Minimizes its Appeal to Adolescents and the Likelihood that Youth and Adolescents Will Initiate Smokeless Tobacco or Smokeless Tobacco with Other Products

Bonnie Halpern Felsher from Stanford, in collaboration with colleagues at UCSF submitted this comment to FDA on RJR's application to market Camel Snus as a less dangerous product. The tracking number on regulations.gov is 1k2-9510-ujes. A PDF of the co
Center for Tobacco Control Research and Education (UCSF)
added Aug 26, 2018 14:50
5 Views

GLANTZ: Reynolds’ own data do not support their claim that because exclusive users of Camel Snus experience lower levels of exposure to some toxicants, they will reduce their risk of harm from lung cancer, oral cancer, respiratory disease, and heart dise

My colleagues at UCSF have submitted this public comment to FDA regarding RJR's application to sell Camel Snus as a reduced risk product. The tracking number at regulations.gov is 1k2-9510-3zjn. A PDF of the comment is here.
Center for Tobacco Control Research and Education (UCSF)
added Aug 26, 2018 14:48
4 Views

GLANTZ: Clinical Trials and Observational Epidemiology Indicate that Allowing Snus to be Marketed with Modified Risk

My colleagues and I at UCSF have submitted this public comment to FDA on RJR's application to market Camel Snus as less dangerous. The tracking number on regulations.gov is 1k2-9510-3515. A PDF of the comment is here.
Center for Tobacco Control Research and Education (UCSF)
added Aug 26, 2018 14:43
8 Views

GLANTZ: Two new peer reviewed papers discuss how PMI's own data shows they are as dangerous, maybe worse, than cigarettes

As the title " PMI’s own in vivo clinical data on biomarkers of potential harm in Americans show that IQOS is not detectably different from conventional cigarettes" indicates, PMI's own data shows that the measures of health impact that IQOS has are not
Center for Tobacco Control Research and Education (UCSF)
added Aug 26, 2018 14:39
2 Views

[Asia, Israel] JUUL e-cigarette company petitions High Court over ban

The company accuses the Israeli government of upholding a double standard with regard to their vaping product — which they claim is designed solely to wean long-time smokers off cigarettes — in that the Jewish state continues to allow tobacco companies
Times of Israel (is)
added Aug 25, 2018 14:34
Sign up for daily headlines All Headlines Featured Headlines U.S. Headlines International Headlines